Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adenosine kinase inhibition promotes survival of fetal adenosine deaminase–deficient thymocytes by blocking dATP accumulation
C. Justin Van De Wiele, James G. Vaughn, Michael R. Blackburn, Catherine A. Ledent, Marlene Jacobson, Hong Jiang, Linda F. Thompson
C. Justin Van De Wiele, James G. Vaughn, Michael R. Blackburn, Catherine A. Ledent, Marlene Jacobson, Hong Jiang, Linda F. Thompson
View: Text | PDF
Article Genetics

Adenosine kinase inhibition promotes survival of fetal adenosine deaminase–deficient thymocytes by blocking dATP accumulation

  • Text
  • PDF
Abstract

Research Article

Authors

C. Justin Van De Wiele, James G. Vaughn, Michael R. Blackburn, Catherine A. Ledent, Marlene Jacobson, Hong Jiang, Linda F. Thompson

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
A transgenic TCRβ chain partially corrects the effects of ADA inhibition...
A transgenic TCRβ chain partially corrects the effects of ADA inhibition. FTOCs were performed at day 14 of gestation with or without 5 μM dCF with thymuses from control littermates (a and b) and TCRβ chain transgenic mice (c and d). After 2 days, thymocytes were harvested, counted, and stained with FITC-anti-CD4, PE-anti-CD8, and PI to exclude dead cells. (e) The degree of rescue of thymocyte differentiation (mean ± SD) is shown as a function of the length of the culture period. The “% rescue” is defined as (number of DP thymocytes per lobe from dCF-treated transgenic cultures)/(number of DP thymocytes per lobe from control transgenic cultures) × 100. The number of experiments for each time point is shown beneath each bar.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts